The conventional in vitro assays for genotoxicity assessment of chemicals are characterised by a high false-positive rate, thus failing to correctly predict their in vivo genotoxic effects. This study aimed to identify the cellular mechanisms induced by the false-positive genotoxins quercetin, 8-Hydroxyquinoline and 17-beta oestradiol in comparison to true genotoxins and non-genotoxins, by combining in vitro phenotypic parameters with transcriptomics data from HepG2 cells. The effects of these compounds on the phosphorylation of H2AX, cell cycle distribution and whole genome gene expression following treatment for 12, 24 and 48 h were compared with the effects of true genotoxins [benzo[a]pyrene and aflatoxin B1] and non-genotoxins (2,3,7,8-tetrachlorodibenzodioxin, cyclosporin A and ampicillin C). Quercetin induced similar phenotypic effects as true genotoxins and to some extent similar gene expression alterations. Different gene expression changes were also observed, including the up-regulation of DNA repair-related genes. 8-Hydroxyquinoline and 17-beta oestradiol showed no similarities to the true genotoxins at both the phenotypic and the transcriptomic level. In a classification approach, classifiers were selected to discriminate between genotoxins and non-genotoxins. Subsequent analysis for the false-positive compounds showed quercetin to be predicted as genotoxic and 8-hydroxyquinoline and 17-beta oestradiol as non-genotoxic. Our results support that transcriptomics analysis of compound effects in HepG2 leads to similar results with phenotypic analysis and provides additional mechanistic information. Therefore, combined evaluation of gene expression alterations and relevant functional end points using HepG2 cells may contribute to the better understanding of modes-of-action of chemicals and the correct evaluation of their genotoxic properties.
Introduction
The conventional in vitro assays for evaluating DNA-damaging properties of chemicals often fail to correctly assess genotoxic effects of compounds in vivo (1) . The currently approved assays by regulatory authorities for the in vitro genotoxicity assessment are: the bacterial mutation assay (Ames assay), the mammalian micronuclei assay, the chromosomal aberration assay and the mouse lymphoma assay (2) . All these assays have high rates of false-positive results (1, 3) . Therefore, several efforts are made for the reduction of the false-positive rates of genotoxicity testing. These include the application of mutant cell lines (4) or the reduction of the selected dose for the conventional assays (5) as well as the development of new alternative in vitro methods (6) (7) (8) (9) . However, none of the above studies is focussing on the mechanisms of the compounds that are falsely classified.
Whereas the key mechanism-of-action of true genotoxins (GTX) is the induction, direct or after metabolic activation, of DNA damage, false-positive genotoxins (FPGTX) show positive results in in vitro genotoxicity assays, by causing either mutagenicity or clastogenicity, but show negative results in in vivo genotoxicity assays. Generally, the failure of the standard in vitro test battery to correctly evaluate the in vivo genotoxic properties of chemicals may frequently be due to the lack of the ability of in vitro systems to fully mimic the in vivo situation of the correct target cells or tissue. This can be caused by metabolic activation differences, since in vitro an artificial metabolic activation system of rat liver S9-mix is used; target cell, tissue or species differences; differences at cell-cell interactions and interplays or differences at cellular receptors and transporters between in vitro and in vivo situations (10) .
In order to improve in vitro evaluation of genotoxic properties of chemicals, a better understanding is required of the mechanisms-of-action for false-positive chemicals, ideally to be obtained with in vitro methods (11) . Toxicogenomics-the evaluation of gene expression alterations in cells or tissues after treatment with toxic substances-is proposed as a tool to better understand the mechanisms-of-actions of chemicals (12) . Several studies support this (13) (14) (15) . Therefore, here we studied whether the combination of toxicogenomics with phenotypic effects provides relevant information for understanding in vitro genotoxic mechanisms.
We aimed to identify the molecular pathways modified by FPGTX in HepG2 cells, by combining phenotypic changes with transcriptomic data. Despite the obvious limitations with regard to similarities to primary human hepatocytes, the human hepatic cell line HepG2 is frequently used in toxicology and pharmacology. HepG2 have been repeatedly shown to overexpress many drug metabolising, Phase I and II, enzymes especially after exposure to toxins (16) (17) (18) (19) (20) (21) . Additionally, transcriptomics analysis of HepG2 confirmed activated biotransformation pathways already at baseline levels (22) . HepG2 have been proven a useful tool for genotoxicity studies since genotoxicity induced by chemicals that require metabolic activation is detected in HepG2 by means of micronuclei, sister chromatid exchange assays and single-cell gel electrophoresis (7, 17, 23, 24) ; HepG2 lack mutations in p53, which is a major factor in DNA damage response (25) (26) (27) and they have been successfully used to discriminate GTX from non-genotoxins (NGTX) using transcriptomics-based classification tools (28) (29) (30) (31) as well for the identification of hepatotoxic compounds (32, 33) .
In this study, the known FPGTX compounds quercetin (Que), 8-Hydroxyquinoline (8HQ) and 17-beta oestradiol (E2) were examined and compared with the GTX compounds benzo[a]pyrene (BaP) and aflatoxin B1 (AFB1) and the NGTX compounds 2,3,7,8-tetrachlorodibenzodioxin (TCDD), cyclosporin A (CsA) and ampicillin C (AmpC). Several in vitro genotoxicity studies resulted in positive outcomes for Que, 8HQ and E2 (34) (35) (36) . All three chemicals, however, showed negative results in in vivo genotoxicity assays (Table I and  references therein) . Que and 8HQ also show negative results in carcinogenicity studies, whereas E2 is considered a human carcinogen (55) .
For the phenotypic analysis, firstly, the phosphorylation levels of the histone variant H2AX at Ser-139 (cH2AX) were evaluated in order to confirm the presence/absence of the genotoxic potential of the selected compounds in HepG2 cells. cH2AX is a new marker of genotoxicity (56) and an immediate response to the occurrence of double DNA strand breaks (57) . Secondly, the cell distribution in the different cell cycle phases was evaluated. First, as an additional confirmation of the genotoxic effects of the selected compounds in view of the fact that DNA damage can activate cell cycle checkpoints and inhibit DNA synthesis; thus genotoxic treatments often alter the cell cycle distribution and lead to an accumulation of cells in the S-phase (58) . Secondly, non-genotoxic compounds may cause other effects on the cell cycle. For instance, CsA and TCDD have been reported to cause G1 phase arrest (59, 60) . The transcriptomics data were used to identify genes correlated with the induced levels of DNA damage and cell cycle distributions, for functional annotation analysis of gene expression alterations per chemical as well as for selection of genes with the potential to discriminate GTX from NGTX compounds. Both the phenotypic and transcriptomics analysis aimed to identify similarities and differences in the induced molecular mechanistic pathways in HepG2 cells between FPGTX and GTX and FPGTX and NGTX.
Materials and Methods
Cell culture and treatment HepG2 cells were cultured in six-well plates as previously described (28) . When the cells were 80% confluent, medium was replaced with fresh medium containing the corresponding dose of each compound diluted in 0.5% dimethyl sulfoxide (DMSO) or 0.5% DMSO as a vehicle control (Table I ). All chemicals were obtained from Sigma-Aldrich, except E2 (Steraloids Inc) and TCDD (Cerilliant). For obtaining comparable results, all doses were selected based on an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) cytotoxicity assay resulting in 80% viability after 72 h treatment (28) . Cells were exposed for 12, 24 or 48 h. These exposure periods were selected based on several reasons. Firstly, the phenotypic induction of DNA damage is detected after relatively short exposure times, whereas the differences in gene expression changes induced by GTX and NGTX are more predominant after longer exposure periods (56, 61) . Other reasons are the period that is needed to metabolise the GTX compounds (28) and the cell cycle duration of HepG2 cells ($20 h) (26) .
Thereafter, cells were either methanol fixated and stored at À20°C for flow cytometric analysis or the culture medium was replaced by TRIZOL (Gibco BRL) for RNA isolation. Three independent biological replicates were conducted.
Flow cytometric analysis for cH2AX and cell cycle Methanol-fixated cells were washed with phosphate-buffered saline containing 1 mg/ml bovine serum albumin (PBS/BSA) and incubated for 1 h with the primary antibody mouse anti-phospho-histone H2AX (Ser-139) Clone JBW 301 (Upstate) diluted 1:1000 in PBS/BSA. Cells were washed and incubated for 1 h with the secondary antibody Alexa Fluor 488-conjugated anti-mouse IgG (Invitrogen). Cells were re-suspended in 0.5 ml PBS containing 20 lg/ml propidium iodide (Sigma-Aldrich) and 100 lg/ml RNAse A (Sigma-Aldrich). As positive and negative controls, cells were incubated with 5 lM etoposide (CAS: 33419-42-0; Sigma-Aldrich) and DMSO, respectively (56) . FACSort (Becton Dickinson, Sunnyvale, CA, USA) was used for flow cytometric analysis as previously described (62) . Cells with significant amounts of anti-phospho-Histone H2AX-positive signals were displayed as a percentage of total cells. Cell cycle was analysed using ModFit LT for Mac (version 2.0). Cells in the G0/G1-, S-or G2/M-phase were expressed as a percentage of the total cells.
Values for both cH2AX and cell cycle were considered significant in comparison to control cells when P-value ,0.05 (paired t-test).
Total RNA isolation and microarray experiments Total RNA was extracted using 0.5 ml TRIZOL according to the manufacturer's instructions and purified using RNeasyÒ Mini Kits (Qiagen). Sample preparation, hybridisation, washing, staining and scanning of the Affymetrix Human Genome U133 Plus 2.0 GeneChip arrays were conducted according to the manufacturer's manual as previously described (28) . Quality controls were within acceptable limits. Hybridisation controls were called 'present' on all arrays and yielded the expected increases in intensities. The data in this publication are accessible in EBI's ArrayExpress (http://www.ebi.ac.uk/microarray-as/ae/) through the accession number E-MEXP-2574.
Annotation and normalisation of microarray data
The obtained data sets were re-annotated to the MBNI Custom CDF-files (http://brainarray.mbni.med.umich.edu/Brainarray/Database/CustomCDF/ genomic_curated_CDF.asp) (63) and RMA normalised (64) using the NuGOExpressionFileCreator in GenePattern (65) . MAS5 normalisation was conducted for the retrieval of presence and absence calls. Data filtering was conducted for each treatment and time point separately. Genes with more than four absence calls within the three replicates of each treatment and the three corresponding control replicates were omitted from the data. Only the filtered data sets ($10000 per treatment) were further used.
Selection of differentially expressed genes
Log2 ratios of treatments to the corresponding control treatments were calculated in Microsoft Excel. Differentially expressed genes (DEGs) per compound and time point were selected using the criteria: absolute average fold change .1.5 in comparison to control, absolute fold change .1.2 for at least two replicates and same direction of expression for all three replicates. No statistical criteria were used since it has been reported that reproducibility of microarray data is higher when only fold change criteria are used (66) . A combination of the DEGs resulting after treatment with GTX and NGTX were used for Hierarchical Clustering Analysis (HCA; Euclidean distance, pairwise complete distance) in Genepattern v3.2.1. and for Principal Component Analysis (PCA) by ArrayTrack (67) .
Correlation analysis
Spearman's correlation coefficient was calculated in GEPAS 4.0 (http:// gepas.bioinfo.cipf.es/) for: (i) the levels of induced DNA damage, expressed as log2 ratio of the percentage of cells with significant levels of cH2AX to the control cells and the log2 ratio of the mRNA levels as resulted from the whole genome gene expression analysis and (ii) the number of cells in the different cell cycle phases, expressed as log2 ratio of the percentage of cells in each cell cycle phase to the control cells and the log2 ratio of the mRNA levels as resulted for the whole genome gene expression analysis. For the correlation analysis, only the GTX and the NGTX treatments for all time points (12, 24 and 48 h) were used. Significantly associated genes were considered those for which the mRNA levels showed a correlation coefficient with a false discovery rate ,0.05.
The expression values of the significantly associated genes (log2 ratios) for all treatments were used for PCA in ArrayTrack and HCA (Euclidean distance, pairwise complete-linkage) in GenePattern v.3.2.1. Relative, discrete colour scheme was used for the HCA images.
Prediction analysis PAM (Prediction Analysis for Microarrays 2.13, Stanford University Software) analysis was conducted to select genes that can discriminate between GTX and NGTX compounds. For that reason, the DEGs resulting from each compound and incubation time were combined. As input for PAM analysis, the expression values of this union for each treatment and time point combination were used (68) . As a training set, the log2 ratios of the GTX and the NGTX treatments for each time point were used, whereas as a test set, the log2 ratios of the GTX, NGTX and FPGTX were used. The threshold was set to 4.2 since it fulfilled the criteria of (i) highest average probability, which was calculated as the average of the probabilities of each treatment to be discriminated to its true class and (ii) the lowest number of genes used for the classification (28).
Network and functional annotation analysis Network Analysis was conducted in MetaCore Network Tools (GeneGo, San Diego, CA, USA), using the auto-expand option and limit of 15 nodes. Only positive and negative interactions were used for the image. Functional Annotation based on Gene Ontology (GO) Biological Processes was done using the Database for Annotation, Visualisation and Integrated Discovery (DAVID) (69) . Functional annotation was conducted separately for the up-and down-regulated DEGs for each treatment and time point. For each gene list, a corresponding background list resulting from the data filtering was used. GO terms were considered significant when EASE , 0.1 and P-value ,0.05. The same criteria were applied for the selection of significant GO terms of the correlated genes.
Results
Analysis of phenotypic end points of genotoxicity DNA damage. The levels of induced DNA damage were evaluated in order to verify the in vitro genotoxic properties of true GTX and the absence of in vitro genotoxicity for the NGTX used in this study as well as to evaluate the in vitro genotoxic effects of the FPGTX in HepG2 cells. For that purpose, the cellular levels of cH2AX foci after treatment with the different compounds was quantified ( Figure 1A ). As expected, both GTX significantly induced cH2AX levels and all three NGTX did not cause DNA damage. Regarding the FPGTX, Que caused significant levels of cH2AX after 12 and 24 h and 8HQ resulted in a small but significant increase of cH2AX-positive cells only after 24 h, whereas E2 did not cause any DNA damage.
Cell cycle distribution. Since DNA damage can activate different cell cycle checkpoints and lead to cell cycle arrest (58), we further investigated the effect of the different compounds on the cell cycle distribution. For that purpose, we quantified the percentage of cells in the different cell cycle phases ( Figure 1B ). Both GTX resulted in an accumulation of cells in S-phase and in a decreased number of cells in G0/G1-phase after 24 h. After 48 h, BaP-treated cells showed a similar pattern to the control cells, while AFB1-treated cells showed a significant increase of the number of cells in G2/M-phase.
From the NGTX group, none caused an increase in S-phase cells. CsA, however, caused a significant increase of the number of cells in G0/G1-phase after 12 and 48 h and a decrease in G2/M-phase after 24 and 48 h.
None of the FPGTX caused any significant effect on the cell cycle after 12 or 24 h. After 48 h, 8HQ and E2 induced small but significant increases of the number of cells in S-phase.
Whole genome gene expression analysis Initially, the DEGs resulting after treatment with the different compounds at various time points were identified (Table II, supplementary data 2, available at Mutagenesis Online). To reveal the similarities/differences of the expression changes induced by FPGTX to that of GTX and NGTX, only the DEGs after GTX and NGTX treatments were used for HCA and PCA (Figure 2 A-C) .
In the PCA plots for each time point, Que appears distinct from any other treatment, whereas 8HQ and E2 appear closely related to CsA and AmpC. In addition, the dendrograms for the three individual time points show a major distance between Que and the rest of the treatments and a very close relation of 8HQ with AmpC, whereas for E2, a closer relation to AFB1 is observed at 12 h, but at later time points, E2 appears closely related to AmpC. Association of the phenotypic end points of genotoxicity with gene expression Next, we identified the genes significantly associated over time with levels of DNA damage or cell cycle distribution after GTX and NGTX treatments and the GO processes that they were involved in (supplementary data 1, available at Mutagenesis Online). These genes were also used for HCA and PCA to reveal the similarities/differences of the expression changes of those genes induced by the FPGTX with those induced by GTX and NGTX ( Figure 3A-B) .
DNA damage. Correlation analysis revealed 115 genes associated with the levels of cH2AX over time. Functional annotation analysis revealed several of these genes to be involved in metabolic processes (supplementary data 1, available at Mutagenesis Online). In the HCA of all treatments based on expression levels of the cH2AX-associated genes ( Figure 3A) , two main clusters are observed; one containing the GTX and Que and the second containing the NGTX, 8HQ and E2. This reveals a similar mRNA expression pattern for the DNA damage-associated genes for Que to that induced by GTX and a similar mRNA expression pattern for these genes for 8HQ and E2 to the NGTX. In the PCA plot of all the treatments using the cH2AX-associated genes, however, only the earliest exposure time of Que appears to be similar to the GTX, whereas 8HQ and E2 are again closer to the NGTX.
Cell cycle. Spearman's correlation analysis resulted in 154 genes significantly associated with the cell population in G0/ G1-phase, 8 with the cell population in S-phase, that were also correlated with G0/G1 phase, and only 1 gene with the cell population in G2/M-phase. The functional annotation analysis of these genes revealed several GO terms related to cell cycle and DNA repair (supplementary data 1, available at Mutagenesis Online). Figure 3B shows the HCA/PCA for all treatments based on cell cycle-associated genes. Clear differences are observed for the expression patterns of these genes for GTX and NGTX. Correspondingly to the DNA damage-associated genes, Que resulted in expression patterns similar to the GTX treatments, whereas 8HQ and E2 profiles equal to the NGTX. In the PCA plot, however, Que appears distant from the GTX, whereas 8HQ and E2 are again close to the NGTX.
Functional annotation analysis
To explore the underlying mechanisms that might shed light on the FPGTX mechanisms, the DEGs resulted after treatment with these compounds were functionally annotated by DAVID (Table II) . The resulting significant GO terms that appeared to be strongly represented among the up-or down-regulated DEGs after FPGTX treatments were further compared with the resulting union of the significant GO terms of the GTX treatments and the union of the significant GO terms of the NGTX treatments to identify (i) processes that might explain the in vitro genotoxic effect of these compounds, (ii) processes that might explain the in vivo non-genotoxic effect of these compounds and (iii) processes related to each of the FPGTX compounds (Table III) . All the affected GO terms for all the compounds can be found in supplementary data 3 (available at Mutagenesis Online). For all the compounds, multiple 
Fig. 2. HCA/PCA of all the treatments using the DEGs of GTX and NGTX treatments for (A) 12 h (1228 DEGs), (B) 24 h (1323 DEGs), (C) 48 h (1616 DEGs).
In the PCA plots, red circles indicate GTX treatments, blue NGTX treatments and green FPGTX treatments.
Chemically induced alterations in HepG2 cells
processes related to responses to a variety of stimuli were represented by both the up-and down-regulated DEGs.
Quercetin. Processes that appeared to be commonly affected by the FPGTX Que and the true GTX included: apoptosis/cell death for the up-regulated DEGs throughout time, cell cycle arrest and positive regulation of biosynthetic processes for the up-regulated DEGs of 24 h, biosynthetic and catabolic processes for the down-regulated DEGs of 24 and 48 h as well as homoeostatic and transport processes for the downregulated DEGs at 48 h. In addition, multicellular organismal processes were commonly affected by Que and GTX for all time points. Processes that were commonly affected by Que and the NGTX included: cell division and mitosis for the downregulated DEGs of 12 h; signal transduction for the upregulated DEGs of both 24 and 48 h; homeostasis and cell communication for the down-regulated DEGs of 48 h; biosynthetic and catabolic processes for the down-regulated DEGs of 48 h. Multicellular organismal processes were also commonly affected by Que and the NGTX at 24 and 48 h.
Processes that appeared to be affected only by Que included: several metabolic, transport-related and multicellular organismal processes throughout time; maintenance of location for the up-regulated DEGs of 12 and 24 h; homeostasis and immune response for the down-regulated DEGs of 24 and 48 h; DNA repair and transcription for the up-regulated DEGs of 24 and 48 h; cell cycle checkpoint and DNA replication for the upregulated DEGs of 48 h; inflammatory response and regulation of enzymatic activity for the down-regulated DEGs of 48 h. Lastly, up-regulated DEGs of 24 h were involved in JAK-STAT signalling, whereas down-regulated DEGs of 48 h were involved in CDC42 signalling cascade.
8-Hydroxyquinoline.
Functional Annotation Analysis of DEGs after treatment with 8HQ did not reveal any GO terms at 12 h. Processes commonly affected by 8HQ and GTX were response to chemical stimulus for the down-regulated DEGs of 24 h and sterol biosynthetic process for the down-regulated DEGs of 48 h. Two processes for the up-regulated DEGs of 48 h were affected by 8HQ and NGTX and both were related to regulation of cell size. Processes affected only by 8HQ included monocarboxylic acid metabolic process and digestion for the up-regulated DEGs of 24 h, aging for the downregulated DEGs of 24 h, metabolic and transport-related processes for the down-regulated DEGs of 48 h. Processes affected only by E2 included multicellular organismal processes at 12 and 48 h; metabolic processes at 48 h; cell cycle regulation for the up-regulated DEGs of 48 h and homeostasis, transport-related processes, G-protein signalling and localisation for the down-regulated DEGs of 48 h.
Prediction analysis
To identify genes with the potential to discriminate between GTX and NGTX compounds, and thus correctly assign the FPGTX as NGTX compounds, we conducted PAM analysis using the union of DEGs resulting from all treatments (Figure 4 ). Ten genes were identified (PVRL4, TP53INP1, PLK2, CDKN1A, FAS, GLS2, PPM1D, C12ORF5, LOC100133390 and TP53I3). These genes led to the correct prediction of all GTX and NGTX compounds for all time points, with a probability of 90% to belong in the correct class ( Figure 4A ). 8HQ and E2 were predicted as NGTX and Que as GTX (Figure 4 ). To further understand the relation of the selected genes with genotoxic mechanisms, network analysis was conducted ( Figure 4B) . The selected gene set shows a connection with the DNA damage response transcription factors: p53 and SP1.
Discussion
In this study, we aimed at identifying the similarities and the differences between the effects of FPGTX and true GTX-NGTX compounds in HepG2 cells. For that reason, we compared the effects of Que, 8HQ and E2 at the phenotypic as well as at the transcriptomic level with the effects of known GTX and NGTX.
The GTX selected for this study are BaP and AFB1. Both require metabolic transformation to exert their genotoxic properties. BaP needs to be metabolised to benzo[a]pyrene 7,8-diol 9,10-epoxide and AFB1 to AFB1-8,9-exo-epoxide, which covalently binds to DNA thereby forming DNA adducts (70, 71) . Here, we confirm the genotoxic effect of both chemicals in HepG2 cells as they increase the phosphorylation of the histone variant H2AX, a specific marker for DNA double-strand breaks (56) , while the NGTX remain ineffective. Furthermore, both BaP and AFB1 induced S-phase arrest after 24 h of treatment, as it has been previously reported (72, 73) .
The NGTX used in this study were TCDD, CsA and AmpC. The toxic effect of TCDD is considered to be mediated by its binding to the aryl hydrocarbon receptor and the subsequent induction of gene expression, e.g. of CYP1A1 (74) . In our study, CYP1A1 is highly up-regulated after TCDD exposure for all exposure periods. It has been reported that both TCDD and CsA can cause G1-phase arrest (59, 60) . However, in our study, only CsA results in a cell accumulation in G1 phase, whereas TCDD does not alter the cell cycle distribution.
Que is the only FPGTX examined in our study, which phenotypically resembled the effects of GTX compounds. Que induced similar levels of DNA damage and resulted in a similar cell cycle distribution as GTX. Previous studies have also demonstrated the ability of Que to induce the phosphorylation of the histone variant H2AX (75) and to alter the cell cycle distribution by causing either G0/G1 arrest or G2/M arrest in different cell types (76) (77) (78) (79) (80) . In contrast to these, we found Que to induce S-phase arrest in HepG2 cells, similarly to both GTX. However, Que induced different patterns than GTX compounds on the expression levels of the cell cycle-and cH2AX-correlated genes at 24 and 48 h, some of which are involved in p53-mediated DNA repair signalling (Figure 3 ; supplementary data 1, available at Mutagenesis Online). This indicates that at early (12 h) exposure durations Que and GTX may activate similar mechanisms for DNA repair; however, different pathways are activated after longer exposure periods.
By the PCA (Figure 2 ), we observe that Que treatments result in different whole genome gene expression alterations compared to either the GTX or NGTX compounds. In addition, functional annotation of the DEGs after Que treatment revealed mostly differences in comparison to either the GTX or the NGTX compounds. Several signalling pathways were affected only by Que (e.g. regulation of I-kappaB kinase/NF-kappaB cascade at 48 h). The effect of Que on the transcriptional activity of NF-kappaB was previously reported, supporting its anti-inflammatory activity (81) . Among the similarly affected processes by Que and GTX compounds, apoptosis and cell death were induced at all time points, representing effects on DNA damage response pathways but no alteration of the viability of the cells was observed. However, in other cell types, Que can cause cell death (76, 78) .
Que can form transient covalent DNA adducts in vitro (82) and can be transformed to quinone methides, which are DNAreactive intermediates, whereas in vivo Que is enzymatically metabolised to the non-DNA reactive 3#-O-methylquercetin in the absorptive cells of the intestinal epithelium. Thus, the lack of in vivo genotoxicity of Que is currently explained by the fast metabolization of Que to non-DNA-reactive metabolites (34) .
DNA repair processes appeared to be affected at 24 and 48 h by Que. At 24 h, Que induces similar DNA repair mechanisms to GTX compounds which may be p53 dependent and that may result in similar cell distribution at 24 h. At 48 h, however, Que treatments induce the up-regulation of genes involved in nucleotide excision repair mechanisms (i.e. DDB2, ERCC1, GTF2H1, GTF2H4, POLD4, PNKP, PCNA, RFC4 and XPC). This DNA repair mechanism is responsible for the removal of bulky DNA adducts (83) . This in combination with the observations for the expression changes for the cH2AX-and cell cycle-correlated genes further suggests that Que induces DNA repair mechanisms that are not affected by GTX treatments, especially at later time points.
In summary, our study supports the induction of genotoxic effects by Que in vitro and the activation of nucleotide excision repair. This activation of DNA repair enzymes may counteract the DNA damage induced by Que and may further explain why cotreatments of Que with GTX chemicals leads to the reduction of the DNA damage induced by the GTX chemical and may further explain its anti-mutagenic activity (84) (85) (86) .
The other two FPGTX compounds examined in this study, 8HQ and E2, showed no similarities with any GTX compound, neither at the phenotypic nor at the transcriptomic level. A proposed mechanism for the in vitro genotoxicity of 8HQ refers to its property as a chelating agent to bind iron and thereby causing DNA strand breaks (87) . In vivo studies show that 8HQ is not GTX (37) . With respect to the transcriptomic responses to 8HQ, only a limited number of DEGs could be identified, which are similar to those induced by the NGTX. In particular, 8HQ seems closely related to the non-carcinogenic compound AmpC (88) . This observation is in agreement with the fact that 8HQ is non-carcinogenic (35) . In our study, we observe the genotoxic effects of 8HQ only at a phenotypic level; initially by the induction of the phosphorylation of H2AX at 24 h and then by a delayed increase of the cell fraction in S-phase at 48 h. Transcriptomic analyses show no similarities of 8HQ with the true in vivo GTX compounds. This confirms that also the H2AX assay gives a false-positive result for this compound, whereas the genomic analyses provide a correct assessment.
Regarding E2, in contrast to previous findings in MCF-7 cells (89), it did not induce the phosphorylation of H2AX in HepG2 cells. E2 treatments resulted in a small increase in the number of cells in S-phase only after the longest exposure period, whereas both GTX induced an S-phase arrest at 24 h. In MCF-7 cells, it has been described that E2 increases the cell fraction in S-phase only after short exposure times, whereas for longer exposure periods E2 leads to G2/M arrest (90) . The phenotypic effect of E2 on the cell cycle in our study is also supported by the transcriptomics analysis, where we observe the induction of the expression of genes involved in cell cycle regulation only at 48 h. Furthermore, the transcriptomic changes induced by E2 are similar to those induced by NGTX. In particular, E2 appears close to the carcinogenic compound CsA (91) . The functional annotation analysis of the DEGs after E2 treatment revealed several negatively affected processes. Among them, blood vessel development was identified at the shortest exposure period. In agreement with this, it has been reported that E2 promotes angiogenesis (92) , whereas the E2 metabolite 2-methoxyestradiol inhibits angiogenesis (93) .
E2 needs to be metabolised in order to exert its genotoxic activity in vitro and to lead to DNA-adducts formation (36) . Particularly, E2 is transformed to either 4-hydroxyestradiol by CYP1B1 or to 2-hydroxyestradiol by CYP1A1, CYP1A2 or CYP3A4 (94) . In humans and animals, 2-hydroxyestradiol is further detoxified, among others, by COMT and SULT1A1 (95) . The activity of 2-hydroxyestradiol for the formation of DNA adducts and the production of reactive oxygen species has been proven to be lower in comparison to the activity of 4-hydroxyestradiol (96, 97) . In our study, E2 induces the expression of CYP1A1 (log2 ratios of 1.45, 1.16 and 0.92 for 12, 24 and 48 h, respectively) but not of CYP1B1 throughout time, and thus likely increases the CYP1A1 enzymatic activity. This together with the results of the functional annotation analysis suggest that HepG2 cells metabolise E2 to 2-hydroxyestradiol instead of to 4-hydroxyestradiol and this may explain why no significant levels of DNA damage are observed. In summary, E2 is probably metabolised to 2-hydroxyestradiol. Since no expression changes are observed for the enzymes responsible for the further metabolization of 2-hydroxyestradiol, we hypothesise that it may generate free radicals, that although they do not induce significant levels of H2AX phosphorylation, they may be responsible for the cell cycle effect that is observed at 48 h.
Further, the transcriptomics data were used for the selection of a gene-set with the potential to predict correctly the genotoxic effects of the FPGTX compounds. The resulting gene-set led to the prediction of Que as GTX and the prediction of 8HQ and E2 as NGTX (Figure 4) confirming the results of the phenotypic analyses. This gene set appears to be regulated by the DNA damage-related transcription factors p53 and SP1 (98) . These results also suggest that biologically relevant genes for genotoxicity evaluation can be obtained by means of transcriptomics without the association with phenotypic end points. Whether this gene set can predict genotoxicity in general requires the inclusion of many more compounds tested in the same microarray platform and using the same cell line. So far, only one study has been conducted using Affymetrix microarrays to measure compound-induced transcriptomics changes in HepG2 cells, but this study is limited to the analysis of ethanol-induced effects (99) . Several other studies exist that analyse the compound-induced gene expression alterations in HepG2 using, however, other platforms for the analysis (20, 29, (100) (101) (102) . Therefore, a more extended study including more compounds using the same platform for the evaluation of the expression alterations induced in HepG2 cells has to be conducted for evaluation of the ability of transcriptomics to evaluate genotoxic properties. Besides the evaluation of transcriptomics changes induced by different chemicals in HepG2, it is also very important to further evaluate the ability of HepG2 cells to metabolise compounds for which no information is available. Although HepG2 are metabolically competent, the expression of some CYP450 enzymes is not detected or very low (16) . In our study, the expression of the CYP450 enzymes involved in the metabolism of the compounds used, as mentioned above, is detected. In case other compounds are tested in HepG2 cells, characterisation of their metabolites/metabolism may be needed. For those compounds, however, that are metabolised by enzymes absent in HepG2 cells, the application of HepG2 cells over-expressing the absent enzymes should be considered.
In conclusion, from the three FPGTX examined here, only Que showed clear similarities to the GTX used in this study both at the phenotypic and at the transcriptomic level and was also predicted as a GTX compound by PAM analysis; hence pointing out that Que is also for HepG2 cells a true in vitro genotoxin. At the transcriptomic level, however, Que also shows very distinct effects from both BaP and AFB1, such as genes involved in nucleotide excision repair. This may explain the dual nature of Que, namely as an in vitro GTX compound and as an anti-mutagen. Both 8HQ and E2 induced mostly similar responses at both the phenotypic and transcriptomic level as the NGTX and were predicted as NGTX compounds, thus being in vitro non-genotoxins in HepG2 cells. Due to the small numbers of DEGs induced by 8HQ and E2, the functional annotation analysis revealed only a small number of affected processes and therefore does not shed further light on the possible mechanisms that can explain their FPGTX nature. In this study, however, we reveal new mechanisms and support existing hypotheses of the mode-of-actions of Que, 8HQ and E2. Our results support that transcriptomics analysis can be used for the prediction of genotoxic properties. However, the integration of gene expression alterations to relevant functional end points may contribute to understanding the discrepancies between in vitro and in vivo genotoxicity test outcomes and provide relevant mechanistic information.
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